search
Biossil
Trends
- 1OpenAI leads $150M funding round for drug revival startup Biossil▼OpenAI leads $150M round for drug-reviving startup Biossil
OpenAI has led a $150 million investment round in Biossil, a startup focused on reviving abandoned drugs. The company specializes in taking discontinued or shelved pharmaceutical compounds and finding new paths to develop them. It is a notable move for OpenAI's investment arm, signaling growing interest in applying AI to drug discovery and development, and fresh attention on the drug-repurposing sector.